Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2008 3
2009 2
2010 1
2012 2
2013 2
2014 2
2015 4
2016 7
2017 3
2018 4
2019 1
2020 2
2021 2
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy.
Šušak Sporiš I, Božina N, Klarica Domjanović I, Sporiš D, Bašić S, Bašić I, Lovrić M, Ganoci L, Trkulja V. Šušak Sporiš I, et al. Among authors: lovric m. Fundam Clin Pharmacol. 2024 Apr;38(2):351-368. doi: 10.1111/fcp.12958. Epub 2023 Oct 4. Fundam Clin Pharmacol. 2024. PMID: 37793994
Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy.
Božina N, Sporiš IŠ, Domjanović IK, Ganoci L, Šimičević L, Lovrić M, Romić ZČ, Gadže ŽP, Trkulja V. Božina N, et al. Among authors: lovric m. Eur J Clin Pharmacol. 2023 Aug;79(8):1117-1129. doi: 10.1007/s00228-023-03526-z. Epub 2023 Jun 20. Eur J Clin Pharmacol. 2023. PMID: 37340142
Loss of Function ABCG2 c.421C>A (rs2231142) Polymorphism Increases Steady-State Exposure to Mycophenolic Acid in Stable Renal Transplant Recipients: An Exploratory Matched Cohort Study.
Borić-Bilušić AA, Božina N, Lalić Z, Lovrić M, Nađ-Škegro S, Penezić L, Barišić K, Trkulja V. Borić-Bilušić AA, et al. Among authors: lovric m. Adv Ther. 2023 Feb;40(2):601-618. doi: 10.1007/s12325-022-02378-w. Epub 2022 Nov 25. Adv Ther. 2023. PMID: 36434147
Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.
Turković L, Bočkor L, Ekpenyong O, Silovski T, Lovrić M, Crnković S, Nigović B, Sertić M. Turković L, et al. Among authors: lovric m. Pharmaceuticals (Basel). 2022 May 16;15(5):614. doi: 10.3390/ph15050614. Pharmaceuticals (Basel). 2022. PMID: 35631440 Free PMC article.
Verification policies in Croatian medical biochemistry laboratories: a survey of the practice.
Milevoj Kopčinović L, Juričić G, Bokulić A, Vukasović I, Ćelap I, Čičak H, Kocijančić M, Miloš M, Lovrić M, Siter Kuprešanin M, Hrabrić Vlah S, Miletić M. Milevoj Kopčinović L, et al. Among authors: lovric m. Biochem Med (Zagreb). 2022 Jun 15;32(2):020703. doi: 10.11613/BM.2022.020703. Epub 2022 Apr 15. Biochem Med (Zagreb). 2022. PMID: 35464743 Free PMC article.
37 results